Drug ID: | NPD4455 |
Drug Name: | DC-159a |
Molecular Formula: | C21H23F2N3O4 |
Canonical SMILES: | COc1c(c(F)cc2c1n(cc(c2=O)C(=O)O)[C@@H]1C[C@@H]1F)N1CC2([C@](C1)(C)N)CC2 |
Standard InCHI: | InChI=1S/C21H23F2N3O4/c1-20(24)8-25(9-21(20)3-4-21)16-13(23)5-10-15(18(16)30-2)26(14-6-12(14)22)7-11(17(10)27)19(28)29/h5,7,12,14H,3-4,6,8-9,24H2,1-2H3,(H,28,29)/t12-,14+,20+/m0/s1 |
Standard InCHIKey: | GBLYBAYNQGZGCK-KBARZSOFSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB006802 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 419.17 |
ALogP | -1.0243 |
MLogP | 2.78 |
XLogP | 2.462 |
HDA | 6 |
HBD | 2 |
Rotatable Bonds | 10 |
TPSA | 96.1 |
RO5 Violation | 0 |